South Korea In Vitro Diagnostics Market – Size, Outlook, Trends and Forecast (2024 – 2032)

The in-vitro diagnostic is a process where diagnostic tests performed using analytical instruments and reagents on specific samples such as blood, urine, and other body fluids. The samples are gathered from patients or healthy individuals to identify and detect the diseases. The market is valued at USD XX billion in 2017 and is projected to USD XX billion by 2024 at a CAGR of 5.8%.

South Korea In-Vitro Diagnostics Market Share:

IVD plays a vital role in early diagnostics and detection of diseases. The point of care testing segment is holding the most significant share in the market at present.

South Korea In-Vitro Diagnostics Market Size:

South Korea is expected to grow and dominate in forecast due to increasing acceptance of personalised medicine and growing adoption of advanced products and expand in chronic diseases patient pool and technological advancements. Asia-Pacific is expected to have highest CAGR during forecast due to growth in research and increasing investments.

South Korea In-Vitro Diagnostics Market Growth:

The market inclines due to the growth of healthcare expenditure in the emerging markets, the high demand for advanced testing methods, and rise in global GDP per capita and growing geriatric population are the factors influencing the growth of the market.

South Korea In-Vitro Diagnostics Market Industry Analysis:

Application, product divide the market, and service, end user and technology. By application, it is categorised into diabetes, cancer, cardiology, autoimmune disease, drug testing, infectious disease, and nephrology. By the end-user market is segmented into hospitals, laboratories, point care testing, patient-care testing and academic industries. By technology, the market is into the immune disease, clinical chemistry, molecular diagnostics, Clinical microbiology, haematology, coagulation, and hemostasis by product the market is categorised into reagents and kits, instruments, consumables and data management services. By reusability, a market is segmented into reusable IVD devices and disposable IVD devices.

South Korea In-Vitro Diagnostics Market Outlook:

In-vitro means study of microorganisms, cells, biological molecules outside their biological context called test tube experiments. These diagnostics use analytical instruments and reagents on specific samples. North America is the leading one in the In-vitro diagnostics market.

South Korea In-Vitro Diagnostics Market Trends:

• Danaher Corporation is experiencing sustained growth due to mergers and acquisitions.
• Roche and Genentech announced the acquisition of Genentech and Genentech became a wholly owned member of Roche group.
• Roche signed to acquire Viewics, Inc. and Viewics solutions provides efficient integration of big data from a variety of IT systems in the laboratory.
• Abbott Laboratories CEO and chairman announced a deal on February 1, 2016, which is going to create a premier point-of-care and analyse infectious diseases.
• Thermo Fisher Scientific completes acquisition with Patheon, and thermo fisher is the world leader in serving science with higher revenues.

South Korea In-Vitro Diagnostics Market Research Report Includes:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOTanalysis, and Y-o-Y analysis.
• Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
• Identifying DROC in the current market and their impact in altering the market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the major market players, such as
•  Roche Diagnostics
•  Abbott Laboratories
•  Bio-Rad Laboratories, Inc.
•  Danaher Corporation
•  Johnson & Johnson